3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Liver Neoplasms
2
Glioma
2
Disease
2
Carcinoma in Situ
2
Brain Neoplasms
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Prostate Cancer, Hereditary, 7
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Complete Response
1
Papillomavirus Infections
1
Oropharyngeal Neoplasms
1
Muscle Weakness
1
Lymphoma, Non-Hodgkin
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Hypoxia
1
Interventions
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Cisplatin
2
tislelizumab
1
radium Ra 223 dichloride
1
peposertib
1
encorafenib
1
cabozantinib
1
binimetinib
1
avelumab
1
alovudine
1
X-Rays
1
Surgical Procedures, Operative
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Propranolol
1
Platinum Compounds
1
Platinum
1
Pemetrexed
1
Nivolumab
1
Laparoscopy
1
Ipilimumab
1
Gemcitabine
1
DNA Mismatch Repair
1
Conversion to Open Surgery
1
Control Groups
1
Carboplatin
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphatic Metastasis
×
Magnetic Resonance Imaging
×
90 days
×
Clear all
No trials found.